Artículo de publicación ISISin acceso a texto completoBackground: Plasma-derived fractions have been used as an autologous source of growth factors; however, limited knowledge concerning their biologic effects has hampered their clinical application. In this study, the authors analyze the content and specific effect of both platelet-rich plasma (PRP) and platelet-poor plasma (PPP) on osteoblastic differentiation using primary cultures of human periodontal ligament stem cells (HPLSCs). Methods: The authors evaluated the growth factor content of PRP and PPP using a proteome profiler array and enzyme-linked immunosorbent assay. HPLSCs were characterized by flow cytometry and differentiation assays. The effect of PRP and PPP on HPLSC bon...
BACKGROUND:Platelet-rich plasma (PRP) is a medium containing concentrated amounts of growth factors ...
Despite wide clinical application, the efficacy of platelet-rich plasma (PRP) for repairing bone def...
Platelet-rich plasma (PRP) is defined as a portion of the plasma fraction of autologous blood having...
Artículo de publicación ISISin acceso a texto completoBackground: Plasma-derived fractions have been...
Objectives: The use of platelets and platelet products has become increasingly popular clinically as...
BACKGROUND AND OBJECTIVE: Platelet-rich plasma is used to deliver growth factors, in a safe and conv...
Objectives: Platelet-rich plasma (PRP) is at present used in surgical procedures as a topically-appl...
Platelet-rich plasma (PRP) is a new application of tissue engineering and a developing area for clin...
The use of platelet rich plasma (PRP, GLO) has been used as an adjunct to various regenerative denta...
Platelet-enriched plasma (PRP) is used in therapy as a source of growth factors in bone fracture and...
Statement of problem: Platelet-rich plasma(PRP) is well known to be very effective method to stimula...
BACKGROUND The use of platelet rich plasma (PRP, GLO) has been used as an adjunct to various rege...
Background: Osteoblasts’ activity is prerequisite for prevention from and treatment of apical period...
none11noBACKGROUND AIMS: An extensive debate about the clinical benefits of autologous platelet con...
BACKGROUND:Platelet-rich plasma (PRP) is a medium containing concentrated amounts of growth factors ...
BACKGROUND:Platelet-rich plasma (PRP) is a medium containing concentrated amounts of growth factors ...
Despite wide clinical application, the efficacy of platelet-rich plasma (PRP) for repairing bone def...
Platelet-rich plasma (PRP) is defined as a portion of the plasma fraction of autologous blood having...
Artículo de publicación ISISin acceso a texto completoBackground: Plasma-derived fractions have been...
Objectives: The use of platelets and platelet products has become increasingly popular clinically as...
BACKGROUND AND OBJECTIVE: Platelet-rich plasma is used to deliver growth factors, in a safe and conv...
Objectives: Platelet-rich plasma (PRP) is at present used in surgical procedures as a topically-appl...
Platelet-rich plasma (PRP) is a new application of tissue engineering and a developing area for clin...
The use of platelet rich plasma (PRP, GLO) has been used as an adjunct to various regenerative denta...
Platelet-enriched plasma (PRP) is used in therapy as a source of growth factors in bone fracture and...
Statement of problem: Platelet-rich plasma(PRP) is well known to be very effective method to stimula...
BACKGROUND The use of platelet rich plasma (PRP, GLO) has been used as an adjunct to various rege...
Background: Osteoblasts’ activity is prerequisite for prevention from and treatment of apical period...
none11noBACKGROUND AIMS: An extensive debate about the clinical benefits of autologous platelet con...
BACKGROUND:Platelet-rich plasma (PRP) is a medium containing concentrated amounts of growth factors ...
BACKGROUND:Platelet-rich plasma (PRP) is a medium containing concentrated amounts of growth factors ...
Despite wide clinical application, the efficacy of platelet-rich plasma (PRP) for repairing bone def...
Platelet-rich plasma (PRP) is defined as a portion of the plasma fraction of autologous blood having...